Search
GeneDx Holdings Corp
WGSAdd to Watchlist
85.200USD
-5.600-6.17%
Close 09-23 16:00（ET）
2.53BMarket Cap
LossP/E TTM
GeneDx Holdings Corp (WGS) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to GeneDx Holdings Corp in the past month.
Buy
3 Strong Buy
6 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
90.444USD-0.39%
WGS Analyst Recommendation Trends
In the current month, WGS has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. WGS average Analyst price target in the last month is 90.444.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
3
3
3
3
3
3
3
3
6
6
6
6
6
6
6
5
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
9
9
9
9
9
9
WGS Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
CVS Health Corp
CVS
7
18
4
0
0
29
HCA Healthcare Inc
HCA
5
9
11
1
0
26
Teladoc Health Inc
TDOC
2
4
19
0
0
25
Natera Inc
NTRA
10
12
3
0
0
25
Tenet Healthcare Corp
THC
5
14
4
0
0
23
Universal Health Services Inc
UHS
2
4
15
1
0
22
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19
Quest Diagnostics Inc
DGX
5
5
9
0
0
19
Privia Health Group Inc
PRVA
6
12
1
0
0
19
Labcorp Holdings Inc
LH
6
8
5
0
0
19
Financial Forecasting
Based on analysts' estimates, WGS EPS is projected to reach 0.073 in FY2026Q3, following reported EPS of -0.597 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.11
-0.01
-0.19
0.07
0.32
Actual
-0.61
-2.16
-0.60
--
--
Surprise
-645.74%
-21483.70%
-218.45%
--
--
FAQs
What is GeneDx Holdings Corp's expected revenue for the next quarter?
GeneDx Holdings Corp's expected revenue is 122.97M.
What is GeneDx Holdings Corp's price target?
Analysts forecast that GeneDx Holdings Corp's price target is USD 90.44, with the highest forecast at USD 103.00 and the lowest forecast at USD 74.00.
How have GeneDx Holdings CorpWGS's recent earnings per share performed?
The market expectation was USD -0.60, while GeneDx Holdings CorpWGS's earnings per share (EPS) for the previous quarter was USD -2.16. EPS for the next quarter is expected at USD 0.07.
What is the analyst rating for GeneDx Holdings Corp?
Based on the ratings of GeneDx Holdings Corp's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.